We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current AN1 market cap is 3.69M. The company's latest EPS is AUD -0.0168 and P/E is -0.60.
Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Revenue | 8.53M | 7.33M | 10.98M | 9.93M | 10.96M |
Operating Income | -4.6M | -3.04M | -3.92M | -1.67M | -7.47M |
Net Income | -4.91M | -3.39M | -3.65M | -2.67M | -7.74M |
Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Assets | 14.89M | 13.29M | 12.93M | 11.11M | 6.45M |
Total Liabilities | 5.08M | 2.86M | 4.64M | 2.22M | 3.74M |
Total Equity | 9.81M | 10.43M | 8.29M | 8.9M | 2.71M |
Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Operating | -4.01M | -4.11M | -2.53M | -1.76M | -1.74M |
Investing | N/A | 478k | -968k | -1.51M | -198k |
Financing | 7.98M | 3.5M | 73k | 2.54M | 994k |
Market Cap | 3.69M |
Price to Earnings Ratio | -0.60 |
Price to Sales Ratio | 0.42 |
Price to Cash Ratio | 2.86 |
Price to Book Ratio | 1.7 |
Dividend Yield | - |
Shares Outstanding | 461.32M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | -68.00% |
52 Week High | 0.026 |
52 Week Low | 0.006 |
Spread (Intraday) | 0 (22.22%) |
Company Name | Anagenics Ltd |
Address |
suite 204 level 2 sydney, new south wales 2000 |
Website | https://www.anagenics.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions